Get the Stockscreener App
82.02
3.59%
2.84
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $82.02, with a volume of 3.32M.
It is up +3.59% in the last 24 hours and down -7.49% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$79.18
Open:
$81.19
24h Volume:
3.32M
Relative Volume:
1.98
Market Cap:
$43.59B
Revenue:
$9.93B
Net Income/Loss:
$1.12B
P/E Ratio:
36.29
EPS:
2.26
Net Cash Flow:
$1.43B
1W Performance:
-6.49%
1M Performance:
-7.49%
6M Performance:
-9.18%
1Y Performance:
-13.96%
1-Day Range:
$80.83
$82.44
1-Week Range:
$78.11
$90.41
52-Week Range:
$78.11
$101.10
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Alcon Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:ALC) - Seeking Alpha
Alcon Posts Q2 Revenue Miss on Softer Market Conditions, Earnings Beat on Lower Tax Rate, Needham Says - MarketScreener
Alcon's Q2 Earnings: A Reassessment of Resilience in a Softening Surgical Market - AInvest
Alcon Shares Sink After Cut to Fiscal Year Sales Guidance - MarketScreener
Needham maintains Buy rating on Alcon stock amid market slowdown By Investing.com - Investing.com Australia
Alcon: Soft First-Half Performance Puts Pressure on New Launches to Ramp Up for Remainder of 2025 - Morningstar
Alcon slips 9% on top-line miss, updated 2025 guidance - MSN
Swiss Market Index Rallies; Alcon, Geberit Shares Down - MarketScreener
Tariffs trip Alcon’s expectations - WFMZ.com
European Stocks Drop as US Technology Selloff Dents Sentiment - Bloomberg.com
Alcon stock price target lowered to $92 at BTIG on weaker market growth - Investing.com
Alcon: More Than Meets The Eye (NYSE:ALC) - Seeking Alpha
Alcon: stock slumps after targets reduced - MarketScreener
Why Is Alcon Stock Sinking Wednesday?Alcon (NYSE:ALC) - Benzinga
Transcript : Alcon Inc., Q2 2025 Earnings Call, Aug 20, 2025 - MarketScreener
Earnings call transcript: Alcon Q2 2025 sees EPS beat, stock drops - Investing.com
Alcon : Second Quarter 2025 Earnings Conference Call Press Release - MarketScreener
Alcon’s Strong EPS Performance and Promising Outlook Justify Buy Rating Despite Revenue and EBIT Challenges - TipRanks
La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
S&P 500 Futures Decline in Premarket Trading; James Hardie Industries, Alcon Lag - Barron's
Alcon Plunges 12.11% on Tariff Impact, Revenue Warning - AInvest
Needham maintains Buy rating on Alcon stock amid market slowdown - Investing.com
Alcon shares fall after it cuts guidance and warns of tariff impact - Reuters
Alcon’s Stock Drops On Lower Revenue Outlook Despite Earnings Beat - Finimize
Alcon slides over 11% on US tariff impact - breakingthenews.net
Alcon Q2 Core Earnings, Sales Rise; Lowers Full-Year Revenue Outlook; Shares Slump Premarket - MarketScreener
Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit - MSN
Alcon Inc. shares fall 10.31% in premarket after lowering 2025 sales forecast and reporting weak Q2 earnings. - AInvest
Alcon cuts 2025 net sales outlook on tariff pressures - MSN
Alcon trims guidance, sees $100 mln hit from U.S. tariffs - Investing.com
Alcon Q2 2025 slides: Announces $1.5B STAAR acquisition amid softening growth - Investing.com
Compared to Estimates, Alcon (ALC) Q2 Earnings: A Look at Key Metrics - sharewise.com
Alcon's Q2 2025 Earnings: Navigating Revenue Softness While Cementing Long-Term Resilience - AInvest
Alcon Reports Higher H1 Net Income and Sales with Strong Global Presence - AInvest
Alcon Posts Higher H1 Net Income, Sales - MarketScreener
Alcon's Q2 2025 Earnings: Navigating Soft Markets and Strategic Expansion - AInvest
Alcon Posts Q2 Loss Amid Revenue Dip; Market Response Signals Mixed Momentum - AInvest
Alcon AG reports results for the quarter ended June 30Earnings Summary - TradingView
Alcon Lifts Earnings Guidance But Falls Short On Revenue - Finimize
Alcon's Q2 Performance and Strategic Challenges: Navigating a Revised Outlook in a Competitive Landscape - AInvest
Alcon’s Strategic Moves: Q2 2025 Results and STAAR Acquisition - TipRanks
Alcon reports Q2 sales up 4% to $2.6 billion, launches new eye treatment - Investing.com
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical - Placera.se
Alcon Reports $287 Million Returned to Shareholders in Q2, Including $121 Million of Stock Repurchases - MarketScreener
Earnings Flash: (ALC) Alcon Q2 Revenue $2.58 Billion Vs. FactSet Est. $2.64 Billion - MarketScreener
Earnings Flash: (ALC) Alcon Q2 Core EPS $0.76 Vs. FactSet Est. $0.73 - MarketScreener
Alcon Q2 Core Earnings, Net Sales Rise; 2025 Revenue Outlook Lowered - MarketScreener
Alcon reports second-quarter 2025 results - MarketScreener
Alcon's Innovation Edge in Cataract Care: A Strategic Catalyst for Growth in Aging Asia-Pacific Markets - AInvest
Alcon's Dominance in Cataract Surgery Innovation and Market Expansion - AInvest
Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS - Stock Titan
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):